Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
reg-snw-11277 | wolf-screen-ratio-mammosphere-adherent | 0.882 | 1.09e-07 | 9.11e-04 | 1.96e-03 | 10 | 9 |
int-snw-6120 | wolf-screen-ratio-mammosphere-adherent | 0.948 | 4.91e-16 | 1.84e-03 | 3.24e-02 | 9 | 8 |
reg-snw-5925 | wolf-screen-ratio-mammosphere-adherent | 0.802 | 2.42e-06 | 4.82e-03 | 8.69e-03 | 8 | 5 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
PSMB1 | 5689 | 61 | 0.688 | 0.901 | 113 | Yes | - |
PPCS | 79717 | 31 | -0.569 | 0.802 | 2 | - | Yes |
RBX1 | 9978 | 115 | 1.185 | 0.934 | 148 | Yes | - |
PPIE | 10450 | 31 | 0.567 | 0.802 | 41 | - | - |
PSMB7 | 5695 | 118 | 0.982 | 0.934 | 90 | Yes | - |
HNRNPC | 3183 | 108 | 1.812 | 0.973 | 181 | Yes | - |
TREX1 | 11277 | 51 | -0.051 | 0.882 | 91 | Yes | - |
OGDH | 4967 | 72 | 0.847 | 0.802 | 126 | Yes | - |
RPE | 6120 | 3 | 0.024 | 0.948 | 34 | - | - |
TFRC | 7037 | 31 | 0.730 | 0.802 | 17 | - | - |
RPSA | 3921 | 120 | 1.327 | 1.151 | 152 | Yes | - |
PGD | 5226 | 89 | 1.201 | 1.106 | 152 | Yes | - |
RPA2 | 6118 | 96 | 1.250 | 1.151 | 76 | Yes | - |
CAD | 790 | 91 | 0.807 | 0.973 | 400 | - | - |
RB1 | 5925 | 31 | -0.102 | 0.802 | 351 | - | - |
PSMB2 | 5690 | 116 | 0.877 | 0.956 | 169 | Yes | - |
NAA10 | 8260 | 5 | 0.668 | 0.983 | 136 | Yes | - |
PSMD11 | 5717 | 124 | 1.095 | 1.106 | 218 | Yes | - |
ACTB | 60 | 134 | 1.153 | 1.151 | 610 | Yes | - |
RUVBL2 | 10856 | 95 | 0.693 | 0.956 | 532 | Yes | - |
RAN | 5901 | 89 | 0.632 | 0.899 | 258 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
RB1 | 5925 | PPCS | 79717 | pd | > | reg.pazar.txt: no annot |
PSMB2 | 5690 | TREX1 | 11277 | pd | < | reg.ITFP.txt: no annot |
RB1 | 5925 | RPA2 | 6118 | pd | > | reg.pazar.txt: no annot |
PGD | 5226 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
CAD | 790 | TREX1 | 11277 | pd | < | reg.ITFP.txt: no annot |
PSMB1 | 5689 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
RPSA | 3921 | PSMD11 | 5717 | pp | -- | int.I2D: IntAct_Yeast |
PGD | 5226 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
ACTB | 60 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB1 | 5689 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast, MINT, YeastHigh, IntAct_Yeast, INTEROLOG, Krogan_Core, MINT_Yeast; int.Mint: MI:0915(physical association) |
RBX1 | 9978 | PPIE | 10450 | pd | <> | reg.ITFP.txt: no annot |
ACTB | 60 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid_Yeast |
RPSA | 3921 | RAN | 5901 | pp | -- | int.I2D: IntAct_Worm, BioGrid_Worm, BIND_Worm, CORE_2, MINT_Worm |
ACTB | 60 | RPSA | 3921 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct_Yeast, IntAct |
RPSA | 3921 | NAA10 | 8260 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | RPE | 6120 | pp | -- | int.I2D: BioGrid_Yeast |
OGDH | 4967 | RB1 | 5925 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | CAD | 790 | pp | -- | int.I2D: IntAct_Yeast |
OGDH | 4967 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
PSMB7 | 5695 | RBX1 | 9978 | pd | < | reg.ITFP.txt: no annot |
CAD | 790 | RUVBL2 | 10856 | pd | < | reg.ITFP.txt: no annot |
CAD | 790 | RUVBL2 | 10856 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
PGD | 5226 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
PSMB7 | 5695 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | NAA10 | 8260 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | RB1 | 5925 | pd | < | reg.ITFP.txt: no annot |
RAN | 5901 | RPE | 6120 | pp | -- | int.I2D: YeastLow |
HNRNPC | 3183 | RUVBL2 | 10856 | pd | < | reg.ITFP.txt: no annot |
PSMB1 | 5689 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0915(physical association), MI:0914(association); int.I2D: BCI, BioGrid_Yeast, BIND_Yeast, HPRD, MINT, YeastLow, IntAct, Krogan_Core, MINT_Yeast, Yu_GoldStd; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
ACTB | 60 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB2 | 5690 | RUVBL2 | 10856 | pd | < | reg.ITFP.txt: no annot |
PSMB2 | 5690 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastLow, IntAct |
CAD | 790 | NAA10 | 8260 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | RAN | 5901 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, NON_CORE |
CAD | 790 | RAN | 5901 | pp | -- | int.I2D: IntAct_Yeast |
PSMB7 | 5695 | TREX1 | 11277 | pd | < | reg.ITFP.txt: no annot |
RPSA | 3921 | RUVBL2 | 10856 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
ACTB | 60 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast |
RPE | 6120 | NAA10 | 8260 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | RPA2 | 6118 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
CAD | 790 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD11 | 5717 | RUVBL2 | 10856 | pp | -- | int.I2D: YeastLow |
OGDH | 4967 | PSMD11 | 5717 | pp | -- | int.I2D: YeastLow |
PGD | 5226 | RPE | 6120 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB7 | 5695 | PPIE | 10450 | pd | < | reg.ITFP.txt: no annot |
PSMB1 | 5689 | RUVBL2 | 10856 | pd | < | reg.ITFP.txt: no annot |
PSMB1 | 5689 | TREX1 | 11277 | pd | < | reg.ITFP.txt: no annot |
RB1 | 5925 | TFRC | 7037 | pd | > | reg.ITFP.txt: no annot |
OGDH | 4967 | RAN | 5901 | pp | -- | int.I2D: YeastLow |
PSMB2 | 5690 | PSMD11 | 5717 | pd | < | reg.ITFP.txt: no annot |
PSMB2 | 5690 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
RB1 | 5925 | PPIE | 10450 | pd | > | reg.pazar.txt: no annot |
RAN | 5901 | TREX1 | 11277 | pd | < | reg.ITFP.txt: no annot |
RUVBL2 | 10856 | TREX1 | 11277 | pd | <> | reg.ITFP.txt: no annot |
ACTB | 60 | RUVBL2 | 10856 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, YeastLow, BioGrid |
CAD | 790 | RPSA | 3921 | pp | -- | int.I2D: IntAct_Yeast |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0016032 | viral process | 9.17e-09 | 1.50e-04 | 3.695 | 9 | 55 | 540 |
GO:0005654 | nucleoplasm | 2.23e-08 | 3.64e-04 | 2.965 | 11 | 83 | 1095 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.64e-08 | 4.31e-04 | 4.958 | 6 | 33 | 150 |
GO:0070062 | extracellular vesicular exosome | 1.64e-07 | 2.68e-03 | 2.113 | 14 | 98 | 2516 |
GO:0005829 | cytosol | 2.07e-07 | 3.38e-03 | 2.086 | 14 | 125 | 2562 |
GO:0006521 | regulation of cellular amino acid metabolic process | 4.49e-07 | 7.33e-03 | 5.958 | 4 | 21 | 50 |
GO:0000502 | proteasome complex | 8.21e-07 | 1.34e-02 | 5.744 | 4 | 22 | 58 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.30e-06 | 2.13e-02 | 5.580 | 4 | 24 | 65 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.30e-06 | 2.13e-02 | 5.580 | 4 | 22 | 65 |
GO:0005839 | proteasome core complex | 1.48e-06 | 2.41e-02 | 7.017 | 3 | 11 | 18 |
GO:0044281 | small molecule metabolic process | 1.50e-06 | 2.44e-02 | 2.585 | 10 | 57 | 1295 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.76e-06 | 2.87e-02 | 5.473 | 4 | 24 | 70 |
GO:0004298 | threonine-type endopeptidase activity | 2.06e-06 | 3.37e-02 | 6.865 | 3 | 11 | 20 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.08e-06 | 3.40e-02 | 5.412 | 4 | 23 | 73 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.20e-06 | 3.59e-02 | 5.393 | 4 | 24 | 74 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.51e-06 | 4.09e-02 | 4.456 | 5 | 25 | 177 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.58e-06 | 4.21e-02 | 5.335 | 4 | 23 | 77 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.86e-06 | 4.66e-02 | 5.298 | 4 | 25 | 79 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 5.73e-06 | 9.35e-02 | 5.048 | 4 | 23 | 94 |
GO:0016071 | mRNA metabolic process | 7.75e-06 | 1.27e-01 | 4.123 | 5 | 34 | 223 |
GO:0000278 | mitotic cell cycle | 8.06e-06 | 1.31e-01 | 3.550 | 6 | 52 | 398 |
GO:0016070 | RNA metabolic process | 1.27e-05 | 2.08e-01 | 3.976 | 5 | 34 | 247 |
GO:0000209 | protein polyubiquitination | 1.32e-05 | 2.16e-01 | 4.744 | 4 | 21 | 116 |
GO:0010467 | gene expression | 1.32e-05 | 2.16e-01 | 3.024 | 7 | 58 | 669 |
GO:0016020 | membrane | 2.22e-05 | 3.62e-01 | 2.154 | 10 | 80 | 1746 |
GO:0042802 | identical protein binding | 2.65e-05 | 4.33e-01 | 3.248 | 6 | 18 | 491 |
GO:0042981 | regulation of apoptotic process | 3.73e-05 | 6.08e-01 | 4.364 | 4 | 26 | 151 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 4.37e-05 | 7.12e-01 | 5.432 | 3 | 5 | 54 |
GO:0006098 | pentose-phosphate shunt | 8.61e-05 | 1.00e+00 | 7.143 | 2 | 3 | 11 |
GO:0005634 | nucleus | 8.97e-05 | 1.00e+00 | 1.272 | 15 | 131 | 4828 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.42e-04 | 1.00e+00 | 6.795 | 2 | 4 | 14 |
GO:0006259 | DNA metabolic process | 2.66e-04 | 1.00e+00 | 6.354 | 2 | 3 | 19 |
GO:0006298 | mismatch repair | 2.95e-04 | 1.00e+00 | 6.280 | 2 | 6 | 20 |
GO:0006281 | DNA repair | 3.22e-04 | 1.00e+00 | 3.558 | 4 | 22 | 264 |
GO:0043044 | ATP-dependent chromatin remodeling | 3.92e-04 | 1.00e+00 | 6.079 | 2 | 4 | 23 |
GO:0043022 | ribosome binding | 5.84e-04 | 1.00e+00 | 5.795 | 2 | 3 | 28 |
GO:0031492 | nucleosomal DNA binding | 5.84e-04 | 1.00e+00 | 5.795 | 2 | 4 | 28 |
GO:0006457 | protein folding | 8.79e-04 | 1.00e+00 | 3.968 | 3 | 8 | 149 |
GO:0050681 | androgen receptor binding | 1.08e-03 | 1.00e+00 | 5.354 | 2 | 4 | 38 |
GO:0030521 | androgen receptor signaling pathway | 1.25e-03 | 1.00e+00 | 5.245 | 2 | 2 | 41 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1.29e-03 | 1.00e+00 | 9.602 | 1 | 1 | 1 |
GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity | 1.29e-03 | 1.00e+00 | 9.602 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 1.29e-03 | 1.00e+00 | 9.602 | 1 | 1 | 1 |
GO:0032558 | adenyl deoxyribonucleotide binding | 1.29e-03 | 1.00e+00 | 9.602 | 1 | 1 | 1 |
GO:0004750 | ribulose-phosphate 3-epimerase activity | 1.29e-03 | 1.00e+00 | 9.602 | 1 | 1 | 1 |
GO:0090230 | regulation of centromere complex assembly | 1.29e-03 | 1.00e+00 | 9.602 | 1 | 1 | 1 |
GO:0004151 | dihydroorotase activity | 1.29e-03 | 1.00e+00 | 9.602 | 1 | 1 | 1 |
GO:0004632 | phosphopantothenate--cysteine ligase activity | 1.29e-03 | 1.00e+00 | 9.602 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 1.29e-03 | 1.00e+00 | 9.602 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 1.29e-03 | 1.00e+00 | 9.602 | 1 | 1 | 1 |
GO:0031625 | ubiquitin protein ligase binding | 1.52e-03 | 1.00e+00 | 3.695 | 3 | 13 | 180 |
GO:0005515 | protein binding | 1.69e-03 | 1.00e+00 | 0.928 | 15 | 172 | 6127 |
GO:0003684 | damaged DNA binding | 1.94e-03 | 1.00e+00 | 4.930 | 2 | 11 | 51 |
GO:0043066 | negative regulation of apoptotic process | 2.04e-03 | 1.00e+00 | 2.844 | 4 | 30 | 433 |
GO:0045252 | oxoglutarate dehydrogenase complex | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 2 | 2 |
GO:0097286 | iron ion import | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 1 | 2 |
GO:0061034 | olfactory bulb mitral cell layer development | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 1 | 2 |
GO:0008296 | 3'-5'-exodeoxyribonuclease activity | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 1 | 2 |
GO:0004998 | transferrin receptor activity | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 1 | 2 |
GO:0031134 | sister chromatid biorientation | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 2 | 2 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 2.57e-03 | 1.00e+00 | 8.602 | 1 | 1 | 2 |
GO:0006310 | DNA recombination | 3.32e-03 | 1.00e+00 | 4.536 | 2 | 4 | 67 |
GO:0006338 | chromatin remodeling | 3.41e-03 | 1.00e+00 | 4.515 | 2 | 4 | 68 |
GO:0003697 | single-stranded DNA binding | 3.51e-03 | 1.00e+00 | 4.494 | 2 | 9 | 69 |
GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity | 3.86e-03 | 1.00e+00 | 8.017 | 1 | 1 | 3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 3.86e-03 | 1.00e+00 | 8.017 | 1 | 1 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 3.86e-03 | 1.00e+00 | 8.017 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 3.86e-03 | 1.00e+00 | 8.017 | 1 | 1 | 3 |
GO:0071899 | negative regulation of estrogen receptor binding | 3.86e-03 | 1.00e+00 | 8.017 | 1 | 1 | 3 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 3.86e-03 | 1.00e+00 | 8.017 | 1 | 1 | 3 |
GO:0000056 | ribosomal small subunit export from nucleus | 3.86e-03 | 1.00e+00 | 8.017 | 1 | 1 | 3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 3.86e-03 | 1.00e+00 | 8.017 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 3.86e-03 | 1.00e+00 | 8.017 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 3.86e-03 | 1.00e+00 | 8.017 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 3.86e-03 | 1.00e+00 | 8.017 | 1 | 1 | 3 |
GO:0005730 | nucleolus | 3.88e-03 | 1.00e+00 | 1.692 | 7 | 70 | 1684 |
GO:0000785 | chromatin | 3.92e-03 | 1.00e+00 | 4.412 | 2 | 5 | 73 |
GO:0071013 | catalytic step 2 spliceosome | 4.58e-03 | 1.00e+00 | 4.298 | 2 | 7 | 79 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0071922 | regulation of cohesin localization to chromatin | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0043141 | ATP-dependent 5'-3' DNA helicase activity | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0006104 | succinyl-CoA metabolic process | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0006543 | glutamine catabolic process | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0000055 | ribosomal large subunit export from nucleus | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0008853 | exodeoxyribonuclease III activity | 5.14e-03 | 1.00e+00 | 7.602 | 1 | 1 | 4 |
GO:0006915 | apoptotic process | 5.52e-03 | 1.00e+00 | 2.445 | 4 | 34 | 571 |
GO:0016363 | nuclear matrix | 6.16e-03 | 1.00e+00 | 4.079 | 2 | 11 | 92 |
GO:0016605 | PML body | 6.16e-03 | 1.00e+00 | 4.079 | 2 | 5 | 92 |
GO:0042470 | melanosome | 6.16e-03 | 1.00e+00 | 4.079 | 2 | 10 | 92 |
GO:0043234 | protein complex | 6.40e-03 | 1.00e+00 | 2.958 | 3 | 17 | 300 |
GO:0051414 | response to cortisol | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 1 | 5 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 2 | 5 |
GO:0032407 | MutSalpha complex binding | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 1 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 1 | 5 |
GO:0031415 | NatA complex | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 1 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 1 | 5 |
GO:0071169 | establishment of protein localization to chromatin | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 1 | 5 |
GO:0006323 | DNA packaging | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 1 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 1 | 5 |
GO:0030891 | VCB complex | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 2 | 5 |
GO:0000730 | DNA recombinase assembly | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 3 | 5 |
GO:0006734 | NADH metabolic process | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 1 | 5 |
GO:0030976 | thiamine pyrophosphate binding | 6.42e-03 | 1.00e+00 | 7.280 | 1 | 1 | 5 |
GO:0043353 | enucleate erythrocyte differentiation | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 6 |
GO:0009108 | coenzyme biosynthetic process | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 6 |
GO:0006474 | N-terminal protein amino acid acetylation | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 6 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 6 |
GO:0021860 | pyramidal neuron development | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 6 |
GO:0021695 | cerebellar cortex development | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 4 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 1 | 6 |
GO:0032405 | MutLalpha complex binding | 7.70e-03 | 1.00e+00 | 7.017 | 1 | 2 | 6 |
GO:0000028 | ribosomal small subunit assembly | 8.97e-03 | 1.00e+00 | 6.795 | 1 | 1 | 7 |
GO:0004596 | peptide alpha-N-acetyltransferase activity | 8.97e-03 | 1.00e+00 | 6.795 | 1 | 1 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 8.97e-03 | 1.00e+00 | 6.795 | 1 | 2 | 7 |
GO:0006475 | internal protein amino acid acetylation | 8.97e-03 | 1.00e+00 | 6.795 | 1 | 1 | 7 |
GO:0016018 | cyclosporin A binding | 8.97e-03 | 1.00e+00 | 6.795 | 1 | 1 | 7 |
GO:0030529 | ribonucleoprotein complex | 9.31e-03 | 1.00e+00 | 3.769 | 2 | 8 | 114 |
GO:0019058 | viral life cycle | 9.47e-03 | 1.00e+00 | 3.757 | 2 | 10 | 115 |
GO:0072562 | blood microparticle | 9.63e-03 | 1.00e+00 | 3.744 | 2 | 4 | 116 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 1.02e-02 | 1.00e+00 | 6.602 | 1 | 2 | 8 |
GO:0070688 | MLL5-L complex | 1.02e-02 | 1.00e+00 | 6.602 | 1 | 1 | 8 |
GO:0006554 | lysine catabolic process | 1.02e-02 | 1.00e+00 | 6.602 | 1 | 2 | 8 |
GO:0000812 | Swr1 complex | 1.02e-02 | 1.00e+00 | 6.602 | 1 | 3 | 8 |
GO:0045116 | protein neddylation | 1.02e-02 | 1.00e+00 | 6.602 | 1 | 2 | 8 |
GO:0044822 | poly(A) RNA binding | 1.04e-02 | 1.00e+00 | 1.850 | 5 | 50 | 1078 |
GO:0006325 | chromatin organization | 1.08e-02 | 1.00e+00 | 3.660 | 2 | 4 | 123 |
GO:0006260 | DNA replication | 1.11e-02 | 1.00e+00 | 3.636 | 2 | 12 | 125 |
GO:0014075 | response to amine | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 9 |
GO:0015937 | coenzyme A biosynthetic process | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 9 |
GO:0097284 | hepatocyte apoptotic process | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 2 | 9 |
GO:0006228 | UTP biosynthetic process | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 1 | 9 |
GO:0000075 | cell cycle checkpoint | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 2 | 9 |
GO:0031000 | response to caffeine | 1.15e-02 | 1.00e+00 | 6.432 | 1 | 2 | 9 |
GO:0000790 | nuclear chromatin | 1.25e-02 | 1.00e+00 | 3.547 | 2 | 7 | 133 |
GO:0016407 | acetyltransferase activity | 1.28e-02 | 1.00e+00 | 6.280 | 1 | 1 | 10 |
GO:0008080 | N-acetyltransferase activity | 1.28e-02 | 1.00e+00 | 6.280 | 1 | 1 | 10 |
GO:0015939 | pantothenate metabolic process | 1.28e-02 | 1.00e+00 | 6.280 | 1 | 1 | 10 |
GO:0021756 | striatum development | 1.28e-02 | 1.00e+00 | 6.280 | 1 | 1 | 10 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 1 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 3 | 11 |
GO:0042551 | neuron maturation | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 2 | 11 |
GO:0045651 | positive regulation of macrophage differentiation | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 1 | 11 |
GO:0035458 | cellular response to interferon-beta | 1.41e-02 | 1.00e+00 | 6.143 | 1 | 2 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.53e-02 | 1.00e+00 | 6.017 | 1 | 2 | 12 |
GO:0043968 | histone H2A acetylation | 1.53e-02 | 1.00e+00 | 6.017 | 1 | 3 | 12 |
GO:0051146 | striated muscle cell differentiation | 1.53e-02 | 1.00e+00 | 6.017 | 1 | 1 | 12 |
GO:0021794 | thalamus development | 1.53e-02 | 1.00e+00 | 6.017 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 1.53e-02 | 1.00e+00 | 6.017 | 1 | 7 | 12 |
GO:0032479 | regulation of type I interferon production | 1.66e-02 | 1.00e+00 | 5.902 | 1 | 2 | 13 |
GO:0005662 | DNA replication factor A complex | 1.66e-02 | 1.00e+00 | 5.902 | 1 | 3 | 13 |
GO:0045780 | positive regulation of bone resorption | 1.66e-02 | 1.00e+00 | 5.902 | 1 | 1 | 13 |
GO:0000738 | DNA catabolic process, exonucleolytic | 1.66e-02 | 1.00e+00 | 5.902 | 1 | 2 | 13 |
GO:0008266 | poly(U) RNA binding | 1.66e-02 | 1.00e+00 | 5.902 | 1 | 1 | 13 |
GO:0031011 | Ino80 complex | 1.79e-02 | 1.00e+00 | 5.795 | 1 | 3 | 14 |
GO:0000398 | mRNA splicing, via spliceosome | 1.88e-02 | 1.00e+00 | 3.236 | 2 | 12 | 165 |
GO:0045445 | myoblast differentiation | 1.91e-02 | 1.00e+00 | 5.695 | 1 | 2 | 15 |
GO:0035066 | positive regulation of histone acetylation | 1.91e-02 | 1.00e+00 | 5.695 | 1 | 1 | 15 |
GO:0016514 | SWI/SNF complex | 1.91e-02 | 1.00e+00 | 5.695 | 1 | 3 | 15 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.95e-02 | 1.00e+00 | 3.210 | 2 | 5 | 168 |
GO:0050998 | nitric-oxide synthase binding | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 16 |
GO:0006103 | 2-oxoglutarate metabolic process | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 16 |
GO:0008408 | 3'-5' exonuclease activity | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 2 | 16 |
GO:0010243 | response to organonitrogen compound | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 2 | 17 |
GO:0045070 | positive regulation of viral genome replication | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 1 | 17 |
GO:0075733 | intracellular transport of virus | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 2 | 17 |
GO:0022624 | proteasome accessory complex | 2.17e-02 | 1.00e+00 | 5.515 | 1 | 9 | 17 |
GO:0071392 | cellular response to estradiol stimulus | 2.29e-02 | 1.00e+00 | 5.432 | 1 | 1 | 18 |
GO:0006541 | glutamine metabolic process | 2.29e-02 | 1.00e+00 | 5.432 | 1 | 1 | 18 |
GO:0035861 | site of double-strand break | 2.29e-02 | 1.00e+00 | 5.432 | 1 | 1 | 18 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 19 |
GO:0048863 | stem cell differentiation | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 19 |
GO:0003678 | DNA helicase activity | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 3 | 19 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 2.54e-02 | 1.00e+00 | 5.280 | 1 | 2 | 20 |
GO:0005719 | nuclear euchromatin | 2.54e-02 | 1.00e+00 | 5.280 | 1 | 2 | 20 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 2.67e-02 | 1.00e+00 | 5.210 | 1 | 5 | 21 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 2.67e-02 | 1.00e+00 | 5.210 | 1 | 1 | 21 |
GO:0030316 | osteoclast differentiation | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 2 | 22 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 5 | 22 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 3 | 22 |
GO:0033574 | response to testosterone | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 2 | 22 |
GO:0032201 | telomere maintenance via semi-conservative replication | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 7 | 22 |
GO:0030863 | cortical cytoskeleton | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 4 | 22 |
GO:0007052 | mitotic spindle organization | 2.79e-02 | 1.00e+00 | 5.143 | 1 | 2 | 22 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 2.92e-02 | 1.00e+00 | 5.079 | 1 | 2 | 23 |
GO:0043236 | laminin binding | 2.92e-02 | 1.00e+00 | 5.079 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 2.92e-02 | 1.00e+00 | 5.079 | 1 | 1 | 23 |
GO:0045879 | negative regulation of smoothened signaling pathway | 2.92e-02 | 1.00e+00 | 5.079 | 1 | 1 | 23 |
GO:0006206 | pyrimidine nucleobase metabolic process | 3.04e-02 | 1.00e+00 | 5.017 | 1 | 2 | 24 |
GO:0006611 | protein export from nucleus | 3.17e-02 | 1.00e+00 | 4.958 | 1 | 4 | 25 |
GO:0017144 | drug metabolic process | 3.17e-02 | 1.00e+00 | 4.958 | 1 | 1 | 25 |
GO:0000722 | telomere maintenance via recombination | 3.29e-02 | 1.00e+00 | 4.902 | 1 | 7 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 3.29e-02 | 1.00e+00 | 4.902 | 1 | 2 | 26 |
GO:0005622 | intracellular | 3.37e-02 | 1.00e+00 | 2.782 | 2 | 5 | 226 |
GO:0004003 | ATP-dependent DNA helicase activity | 3.42e-02 | 1.00e+00 | 4.847 | 1 | 3 | 27 |
GO:0048565 | digestive tract development | 3.42e-02 | 1.00e+00 | 4.847 | 1 | 1 | 27 |
GO:0071339 | MLL1 complex | 3.42e-02 | 1.00e+00 | 4.847 | 1 | 3 | 27 |
GO:0043967 | histone H4 acetylation | 3.54e-02 | 1.00e+00 | 4.795 | 1 | 3 | 28 |
GO:0019894 | kinesin binding | 3.54e-02 | 1.00e+00 | 4.795 | 1 | 1 | 28 |
GO:0006099 | tricarboxylic acid cycle | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 3 | 29 |
GO:0019005 | SCF ubiquitin ligase complex | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 1 | 29 |
GO:0003730 | mRNA 3'-UTR binding | 3.67e-02 | 1.00e+00 | 4.744 | 1 | 2 | 29 |
GO:0003713 | transcription coactivator activity | 3.74e-02 | 1.00e+00 | 2.701 | 2 | 10 | 239 |
GO:0007346 | regulation of mitotic cell cycle | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 3 | 30 |
GO:0006271 | DNA strand elongation involved in DNA replication | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 9 | 31 |
GO:0007093 | mitotic cell cycle checkpoint | 3.92e-02 | 1.00e+00 | 4.648 | 1 | 2 | 31 |
GO:0050661 | NADP binding | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 1 | 32 |
GO:0051219 | phosphoprotein binding | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 3 | 32 |
GO:0034644 | cellular response to UV | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 5 | 32 |
GO:0033572 | transferrin transport | 4.04e-02 | 1.00e+00 | 4.602 | 1 | 6 | 32 |
GO:0031072 | heat shock protein binding | 4.16e-02 | 1.00e+00 | 4.558 | 1 | 2 | 33 |
GO:0000413 | protein peptidyl-prolyl isomerization | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 34 |
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 1 | 34 |
GO:0034332 | adherens junction organization | 4.53e-02 | 1.00e+00 | 4.432 | 1 | 1 | 36 |
GO:0051402 | neuron apoptotic process | 4.53e-02 | 1.00e+00 | 4.432 | 1 | 2 | 36 |
GO:0001895 | retina homeostasis | 4.53e-02 | 1.00e+00 | 4.432 | 1 | 1 | 36 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 4.66e-02 | 1.00e+00 | 4.393 | 1 | 4 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.66e-02 | 1.00e+00 | 4.393 | 1 | 4 | 37 |
GO:0018107 | peptidyl-threonine phosphorylation | 4.66e-02 | 1.00e+00 | 4.393 | 1 | 1 | 37 |
GO:0000166 | nucleotide binding | 4.72e-02 | 1.00e+00 | 2.515 | 2 | 6 | 272 |
GO:0005975 | carbohydrate metabolic process | 4.78e-02 | 1.00e+00 | 2.504 | 2 | 5 | 274 |
GO:0070527 | platelet aggregation | 4.78e-02 | 1.00e+00 | 4.354 | 1 | 2 | 38 |
GO:0021766 | hippocampus development | 4.90e-02 | 1.00e+00 | 4.317 | 1 | 4 | 39 |
GO:0031490 | chromatin DNA binding | 4.90e-02 | 1.00e+00 | 4.317 | 1 | 2 | 39 |
GO:0006284 | base-excision repair | 4.90e-02 | 1.00e+00 | 4.317 | 1 | 7 | 39 |
GO:0006096 | glycolytic process | 4.90e-02 | 1.00e+00 | 4.317 | 1 | 4 | 39 |
GO:0022627 | cytosolic small ribosomal subunit | 4.90e-02 | 1.00e+00 | 4.317 | 1 | 3 | 39 |
GO:0032092 | positive regulation of protein binding | 4.90e-02 | 1.00e+00 | 4.317 | 1 | 3 | 39 |
GO:0007595 | lactation | 4.90e-02 | 1.00e+00 | 4.317 | 1 | 2 | 39 |
GO:0000781 | chromosome, telomeric region | 5.03e-02 | 1.00e+00 | 4.280 | 1 | 2 | 40 |
GO:0043195 | terminal bouton | 5.15e-02 | 1.00e+00 | 4.245 | 1 | 1 | 41 |
GO:0019899 | enzyme binding | 5.23e-02 | 1.00e+00 | 2.432 | 2 | 11 | 288 |
GO:0035914 | skeletal muscle cell differentiation | 5.27e-02 | 1.00e+00 | 4.210 | 1 | 1 | 42 |
GO:0032508 | DNA duplex unwinding | 5.27e-02 | 1.00e+00 | 4.210 | 1 | 4 | 42 |
GO:0014070 | response to organic cyclic compound | 5.39e-02 | 1.00e+00 | 4.176 | 1 | 3 | 43 |
GO:0007286 | spermatid development | 5.51e-02 | 1.00e+00 | 4.143 | 1 | 1 | 44 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 5.51e-02 | 1.00e+00 | 4.143 | 1 | 2 | 44 |
GO:0021762 | substantia nigra development | 5.76e-02 | 1.00e+00 | 4.079 | 1 | 1 | 46 |
GO:0001047 | core promoter binding | 5.76e-02 | 1.00e+00 | 4.079 | 1 | 2 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.76e-02 | 1.00e+00 | 4.079 | 1 | 8 | 46 |
GO:0019003 | GDP binding | 6.00e-02 | 1.00e+00 | 4.017 | 1 | 2 | 48 |
GO:0031100 | organ regeneration | 6.24e-02 | 1.00e+00 | 3.958 | 1 | 4 | 50 |
GO:0035690 | cellular response to drug | 6.24e-02 | 1.00e+00 | 3.958 | 1 | 2 | 50 |
GO:0006091 | generation of precursor metabolites and energy | 6.36e-02 | 1.00e+00 | 3.930 | 1 | 3 | 51 |
GO:0005905 | coated pit | 6.36e-02 | 1.00e+00 | 3.930 | 1 | 2 | 51 |
GO:0040008 | regulation of growth | 6.36e-02 | 1.00e+00 | 3.930 | 1 | 3 | 51 |
GO:0003725 | double-stranded RNA binding | 6.73e-02 | 1.00e+00 | 3.847 | 1 | 6 | 54 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 6.73e-02 | 1.00e+00 | 3.847 | 1 | 2 | 54 |
GO:0019900 | kinase binding | 6.73e-02 | 1.00e+00 | 3.847 | 1 | 1 | 54 |
GO:0050680 | negative regulation of epithelial cell proliferation | 6.73e-02 | 1.00e+00 | 3.847 | 1 | 1 | 54 |
GO:0006879 | cellular iron ion homeostasis | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 5 | 57 |
GO:0000724 | double-strand break repair via homologous recombination | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 6 | 57 |
GO:0051087 | chaperone binding | 7.33e-02 | 1.00e+00 | 3.719 | 1 | 6 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 7.33e-02 | 1.00e+00 | 3.719 | 1 | 4 | 59 |
GO:0045216 | cell-cell junction organization | 7.33e-02 | 1.00e+00 | 3.719 | 1 | 2 | 59 |
GO:0000723 | telomere maintenance | 7.33e-02 | 1.00e+00 | 3.719 | 1 | 8 | 59 |
GO:0005643 | nuclear pore | 7.33e-02 | 1.00e+00 | 3.719 | 1 | 4 | 59 |
GO:0031966 | mitochondrial membrane | 7.33e-02 | 1.00e+00 | 3.719 | 1 | 1 | 59 |
GO:0003723 | RNA binding | 7.55e-02 | 1.00e+00 | 2.130 | 2 | 19 | 355 |
GO:0032481 | positive regulation of type I interferon production | 7.57e-02 | 1.00e+00 | 3.671 | 1 | 6 | 61 |
GO:0006302 | double-strand break repair | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 8 | 62 |
GO:0019903 | protein phosphatase binding | 7.81e-02 | 1.00e+00 | 3.625 | 1 | 4 | 63 |
GO:0042995 | cell projection | 7.81e-02 | 1.00e+00 | 3.625 | 1 | 6 | 63 |
GO:0006469 | negative regulation of protein kinase activity | 8.04e-02 | 1.00e+00 | 3.580 | 1 | 2 | 65 |
GO:0001558 | regulation of cell growth | 8.16e-02 | 1.00e+00 | 3.558 | 1 | 4 | 66 |
GO:0006289 | nucleotide-excision repair | 8.52e-02 | 1.00e+00 | 3.494 | 1 | 12 | 69 |
GO:0034329 | cell junction assembly | 8.75e-02 | 1.00e+00 | 3.452 | 1 | 1 | 71 |
GO:0055037 | recycling endosome | 8.99e-02 | 1.00e+00 | 3.412 | 1 | 2 | 73 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 8.99e-02 | 1.00e+00 | 3.412 | 1 | 5 | 73 |
GO:0006767 | water-soluble vitamin metabolic process | 9.22e-02 | 1.00e+00 | 3.373 | 1 | 3 | 75 |
GO:0007265 | Ras protein signal transduction | 9.22e-02 | 1.00e+00 | 3.373 | 1 | 3 | 75 |
GO:0031175 | neuron projection development | 9.22e-02 | 1.00e+00 | 3.373 | 1 | 1 | 75 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 9.34e-02 | 1.00e+00 | 3.354 | 1 | 3 | 76 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 9.46e-02 | 1.00e+00 | 3.335 | 1 | 5 | 77 |
GO:0006766 | vitamin metabolic process | 9.58e-02 | 1.00e+00 | 3.317 | 1 | 3 | 78 |
GO:0007565 | female pregnancy | 9.81e-02 | 1.00e+00 | 3.280 | 1 | 2 | 80 |
GO:0019083 | viral transcription | 9.93e-02 | 1.00e+00 | 3.262 | 1 | 8 | 81 |
GO:0001889 | liver development | 1.00e-01 | 1.00e+00 | 3.245 | 1 | 3 | 82 |
GO:0005681 | spliceosomal complex | 1.02e-01 | 1.00e+00 | 3.227 | 1 | 3 | 83 |
GO:0047485 | protein N-terminus binding | 1.05e-01 | 1.00e+00 | 3.176 | 1 | 4 | 86 |
GO:0006898 | receptor-mediated endocytosis | 1.05e-01 | 1.00e+00 | 3.176 | 1 | 2 | 86 |
GO:0006415 | translational termination | 1.06e-01 | 1.00e+00 | 3.159 | 1 | 8 | 87 |
GO:0003690 | double-stranded DNA binding | 1.11e-01 | 1.00e+00 | 3.094 | 1 | 4 | 91 |
GO:0006928 | cellular component movement | 1.12e-01 | 1.00e+00 | 3.079 | 1 | 7 | 92 |
GO:0006414 | translational elongation | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 11 | 93 |
GO:0005200 | structural constituent of cytoskeleton | 1.13e-01 | 1.00e+00 | 3.063 | 1 | 7 | 93 |
GO:0051082 | unfolded protein binding | 1.15e-01 | 1.00e+00 | 3.032 | 1 | 6 | 95 |
GO:0001649 | osteoblast differentiation | 1.15e-01 | 1.00e+00 | 3.032 | 1 | 6 | 95 |
GO:0071456 | cellular response to hypoxia | 1.19e-01 | 1.00e+00 | 2.987 | 1 | 4 | 98 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.26e-01 | 1.00e+00 | 2.902 | 1 | 8 | 104 |
GO:0014069 | postsynaptic density | 1.28e-01 | 1.00e+00 | 2.874 | 1 | 1 | 106 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 1.29e-01 | 1.00e+00 | 2.861 | 1 | 3 | 107 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.29e-01 | 1.00e+00 | 1.674 | 2 | 17 | 487 |
GO:0044267 | cellular protein metabolic process | 1.32e-01 | 1.00e+00 | 1.651 | 2 | 24 | 495 |
GO:0042127 | regulation of cell proliferation | 1.34e-01 | 1.00e+00 | 2.808 | 1 | 4 | 111 |
GO:0015630 | microtubule cytoskeleton | 1.35e-01 | 1.00e+00 | 2.795 | 1 | 5 | 112 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.37e-01 | 1.00e+00 | 2.769 | 1 | 10 | 114 |
GO:0005819 | spindle | 1.37e-01 | 1.00e+00 | 2.769 | 1 | 7 | 114 |
GO:0005635 | nuclear envelope | 1.39e-01 | 1.00e+00 | 2.744 | 1 | 6 | 116 |
GO:0044237 | cellular metabolic process | 1.41e-01 | 1.00e+00 | 2.719 | 1 | 3 | 118 |
GO:0007219 | Notch signaling pathway | 1.49e-01 | 1.00e+00 | 2.636 | 1 | 4 | 125 |
GO:0007050 | cell cycle arrest | 1.50e-01 | 1.00e+00 | 2.625 | 1 | 7 | 126 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.51e-01 | 1.00e+00 | 2.613 | 1 | 5 | 127 |
GO:0006413 | translational initiation | 1.56e-01 | 1.00e+00 | 2.569 | 1 | 12 | 131 |
GO:0031982 | vesicle | 1.59e-01 | 1.00e+00 | 2.536 | 1 | 10 | 134 |
GO:0003735 | structural constituent of ribosome | 1.67e-01 | 1.00e+00 | 2.463 | 1 | 8 | 141 |
GO:0007507 | heart development | 1.67e-01 | 1.00e+00 | 2.463 | 1 | 5 | 141 |
GO:0016887 | ATPase activity | 1.70e-01 | 1.00e+00 | 2.432 | 1 | 7 | 144 |
GO:0061024 | membrane organization | 1.72e-01 | 1.00e+00 | 2.412 | 1 | 5 | 146 |
GO:0046777 | protein autophosphorylation | 1.85e-01 | 1.00e+00 | 2.298 | 1 | 3 | 158 |
GO:0042803 | protein homodimerization activity | 1.87e-01 | 1.00e+00 | 1.333 | 2 | 11 | 617 |
GO:0045087 | innate immune response | 1.87e-01 | 1.00e+00 | 1.335 | 2 | 20 | 616 |
GO:0030424 | axon | 2.00e-01 | 1.00e+00 | 2.176 | 1 | 3 | 172 |
GO:0005768 | endosome | 2.02e-01 | 1.00e+00 | 2.159 | 1 | 5 | 174 |
GO:0004672 | protein kinase activity | 2.06e-01 | 1.00e+00 | 2.126 | 1 | 2 | 178 |
GO:0019904 | protein domain specific binding | 2.09e-01 | 1.00e+00 | 2.102 | 1 | 6 | 181 |
GO:0009897 | external side of plasma membrane | 2.11e-01 | 1.00e+00 | 2.086 | 1 | 4 | 183 |
GO:0032403 | protein complex binding | 2.13e-01 | 1.00e+00 | 2.071 | 1 | 7 | 185 |
GO:0003924 | GTPase activity | 2.31e-01 | 1.00e+00 | 1.937 | 1 | 9 | 203 |
GO:0006184 | GTP catabolic process | 2.48e-01 | 1.00e+00 | 1.821 | 1 | 9 | 220 |
GO:0005524 | ATP binding | 2.51e-01 | 1.00e+00 | 0.784 | 3 | 46 | 1354 |
GO:0007067 | mitotic nuclear division | 2.59e-01 | 1.00e+00 | 1.750 | 1 | 13 | 231 |
GO:0008380 | RNA splicing | 2.60e-01 | 1.00e+00 | 1.744 | 1 | 13 | 232 |
GO:0005759 | mitochondrial matrix | 2.61e-01 | 1.00e+00 | 1.738 | 1 | 12 | 233 |
GO:0006412 | translation | 2.63e-01 | 1.00e+00 | 1.726 | 1 | 15 | 235 |
GO:0008134 | transcription factor binding | 2.73e-01 | 1.00e+00 | 1.660 | 1 | 8 | 246 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.81e-01 | 1.00e+00 | 0.939 | 2 | 19 | 811 |
GO:0043025 | neuronal cell body | 2.81e-01 | 1.00e+00 | 1.613 | 1 | 4 | 254 |
GO:0004842 | ubiquitin-protein transferase activity | 2.83e-01 | 1.00e+00 | 1.602 | 1 | 4 | 256 |
GO:0046872 | metal ion binding | 2.90e-01 | 1.00e+00 | 0.670 | 3 | 24 | 1465 |
GO:0007264 | small GTPase mediated signal transduction | 3.14e-01 | 1.00e+00 | 1.422 | 1 | 3 | 290 |
GO:0016567 | protein ubiquitination | 3.22e-01 | 1.00e+00 | 1.378 | 1 | 5 | 299 |
GO:0006200 | ATP catabolic process | 3.25e-01 | 1.00e+00 | 1.359 | 1 | 14 | 303 |
GO:0005856 | cytoskeleton | 3.33e-01 | 1.00e+00 | 1.321 | 1 | 8 | 311 |
GO:0019901 | protein kinase binding | 3.40e-01 | 1.00e+00 | 1.280 | 1 | 21 | 320 |
GO:0007411 | axon guidance | 3.46e-01 | 1.00e+00 | 1.249 | 1 | 9 | 327 |
GO:0005525 | GTP binding | 3.47e-01 | 1.00e+00 | 1.245 | 1 | 11 | 328 |
GO:0043231 | intracellular membrane-bounded organelle | 3.51e-01 | 1.00e+00 | 1.227 | 1 | 8 | 332 |
GO:0003682 | chromatin binding | 3.52e-01 | 1.00e+00 | 1.218 | 1 | 12 | 334 |
GO:0005615 | extracellular space | 3.76e-01 | 1.00e+00 | 0.622 | 2 | 17 | 1010 |
GO:0005925 | focal adhesion | 3.82e-01 | 1.00e+00 | 1.071 | 1 | 18 | 370 |
GO:0007155 | cell adhesion | 3.94e-01 | 1.00e+00 | 1.017 | 1 | 8 | 384 |
GO:0008270 | zinc ion binding | 4.03e-01 | 1.00e+00 | 0.543 | 2 | 12 | 1067 |
GO:0009986 | cell surface | 4.23e-01 | 1.00e+00 | 0.881 | 1 | 9 | 422 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.25e-01 | 1.00e+00 | 0.874 | 1 | 14 | 424 |
GO:0007596 | blood coagulation | 4.54e-01 | 1.00e+00 | 0.744 | 1 | 14 | 464 |
GO:0055114 | oxidation-reduction process | 4.67e-01 | 1.00e+00 | 0.692 | 1 | 11 | 481 |
GO:0055085 | transmembrane transport | 4.90e-01 | 1.00e+00 | 0.596 | 1 | 8 | 514 |
GO:0048471 | perinuclear region of cytoplasm | 4.96e-01 | 1.00e+00 | 0.571 | 1 | 12 | 523 |
GO:0005789 | endoplasmic reticulum membrane | 5.66e-01 | 1.00e+00 | 0.289 | 1 | 10 | 636 |
GO:0005737 | cytoplasm | 6.07e-01 | 1.00e+00 | -0.033 | 5 | 98 | 3976 |
GO:0006351 | transcription, DNA-templated | 6.19e-01 | 1.00e+00 | -0.028 | 2 | 25 | 1585 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 6.27e-01 | 1.00e+00 | 0.055 | 1 | 11 | 748 |
GO:0007165 | signal transduction | 7.16e-01 | 1.00e+00 | -0.290 | 1 | 17 | 950 |
GO:0005887 | integral component of plasma membrane | 7.21e-01 | 1.00e+00 | -0.306 | 1 | 7 | 961 |
GO:0005739 | mitochondrion | 7.51e-01 | 1.00e+00 | -0.429 | 1 | 24 | 1046 |
GO:0005576 | extracellular region | 7.52e-01 | 1.00e+00 | -0.433 | 1 | 9 | 1049 |
GO:0006355 | regulation of transcription, DNA-templated | 7.70e-01 | 1.00e+00 | -0.506 | 1 | 17 | 1104 |
GO:0003677 | DNA binding | 8.37e-01 | 1.00e+00 | -0.798 | 1 | 26 | 1351 |
GO:0005886 | plasma membrane | 9.02e-01 | 1.00e+00 | -0.866 | 2 | 38 | 2834 |